1. Home
  2. AIMD vs OMH Comparison

AIMD vs OMH Comparison

Compare AIMD & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
    SELLHOLDBUYas of 5 hours ago
  • OMH
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • AIMD 1984
  • OMH 2015
  • Country
  • AIMD United States
  • OMH Singapore
  • Employees
  • AIMD N/A
  • OMH N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • AIMD Health Care
  • OMH Finance
  • Exchange
  • AIMD Nasdaq
  • OMH Nasdaq
  • Market Cap
  • AIMD 7.5M
  • OMH N/A
  • IPO Year
  • AIMD N/A
  • OMH 2023
  • Fundamental
  • Price
  • AIMD $0.54
  • OMH $2.55
  • Analyst Decision
  • AIMD
  • OMH Strong Buy
  • Analyst Count
  • AIMD 0
  • OMH 1
  • Target Price
  • AIMD N/A
  • OMH $15.00
  • AVG Volume (30 Days)
  • AIMD 154.6K
  • OMH 17.0K
  • Earning Date
  • AIMD 03-07-2025
  • OMH 01-01-0001
  • Dividend Yield
  • AIMD N/A
  • OMH N/A
  • EPS Growth
  • AIMD N/A
  • OMH N/A
  • EPS
  • AIMD N/A
  • OMH N/A
  • Revenue
  • AIMD $20,729.00
  • OMH $5,390,607.00
  • Revenue This Year
  • AIMD N/A
  • OMH $111.47
  • Revenue Next Year
  • AIMD N/A
  • OMH $32.08
  • P/E Ratio
  • AIMD N/A
  • OMH N/A
  • Revenue Growth
  • AIMD N/A
  • OMH 25.77
  • 52 Week Low
  • AIMD $0.40
  • OMH $0.25
  • 52 Week High
  • AIMD $1.46
  • OMH $2.70
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 52.13
  • OMH 63.16
  • Support Level
  • AIMD $0.46
  • OMH $2.12
  • Resistance Level
  • AIMD $0.57
  • OMH $2.31
  • Average True Range (ATR)
  • AIMD 0.05
  • OMH 0.22
  • MACD
  • AIMD 0.01
  • OMH -0.07
  • Stochastic Oscillator
  • AIMD 73.45
  • OMH 23.38

Stock Price Comparison Chart: AIMD vs OMH

AIMD
OMH
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April020406080100120140160AIMD VS OMH

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use